C/EBPβ knockdown protects cardiomyocytes from hypertrophy via inhibition of p65-NFκB

Molecular and Cellular Endocrinology

Volumn 390, Issue 1-2, 2014, Pages 18-25

  Zou, Jian ^a,b   Li, Hong ^a   Chen, Xi ^c   Zeng, Siyu ^d   Ye, Jiantao ^a   Zhou, Changhua ^a   Liu, Min ^a   Zhang, Luankun ^a   Yu, Na ^a   Gan, Xiaohong ^b   Zhou, Houfeng ^b   Xian, Zhiwei ^b   Chen, Shaorui ^a   Liu, Peiqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b CHENGDU FIFTH PEOPLE S HOSPITAL   (China)

^c CHANGSHA CENTRAL HOSPITAL   (China)

^d GUANGDONG SECOND PROVINCIAL GENERAL HOSPITAL   (China)

Author keywords

C EBP ; Cardiac hypertrophy; P65 NF B

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PHENYLEPHRINE; TRANSCRIPTION FACTOR RELA; CEBPB PROTEIN, RAT; DNA; PROTEIN BINDING; RELA PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION; ACTIVE TRANSPORT; ANIMAL; CELL CULTURE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE SILENCING; GENETICS; HYPERTROPHY; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELLS, CULTURED; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HYPERTROPHY; MYOCYTES, CARDIAC; PROTEIN BINDING; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTOR RELA;

EID: 84898855977     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.03.007     Document Type: Article

References (29)

1. Asakura M., Kitakaze M., Takashima S., Liao Y., Ishikura F., Yoshinaka T., Ohmoto H., Node K., Yoshino K., Ishiguro H., Asanuma H., Sanada S., Matsumura Y., Takeda H., Beppu S., Tada M., Hori M., Higashiyama S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 2002, 8:35-40.
2. Bostrom P., Mann N., Wu J., Quintero P.A., Plovie E.R., Panakova D., Gupta R.K., Xiao C., MacRae C.A., Rosenzweig A., Spiegelman B.M. C/EBPbeta controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell 2010, 143:1072-1083.
3. Cao Z., Umek R.M., McKnight S.L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 1991, 5:1538-1552.
4. Descombes P., Chojkier M., Lichtsteiner S., Falvey E., Schibler U. LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein. Genes Dev. 1990, 4:1541-1551.
5. Diehl A.M. Roles of CCAAT/enhancer-binding proteins in regulation of liver regenerative growth. J. Biol. Chem. 1998, 273:30843-30846.
6. Fu J.J., Gao H., Pi R.B., Liu P.Q. An optimized protocol for culture of cardiomyocyte from neonatal rat. Cytotechnology 2005, 49:109-116.
7. Greenbaum L.E., Li W., Cressman D.E., Peng Y., Ciliberto G., Poli V., Taub R. CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J. Clin. Invest. 1998, 102:996-1007.
8. Hirata M., Kugimiya F., Fukai A., Ohba S., Kawamura N., Ogasawara T., Kawasaki Y., Saito T., Yano F., Ikeda T., Nakamura K., Chung U.I., Kawaguchi H. C/EBPbeta promotes transition from proliferation to hypertrophic differentiation of chondrocytes through transactivation of p57. PLoS ONE 2009, 4:e4543.
9. Hirotani S., Otsu K., Nishida K., Higuchi Y., Morita T., Nakayama H., Yamaguchi O., Mano T., Matsumura Y., Ueno H., Tada M., Hori M. Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 2002, 105:509-515.
10. Karliner J.S., Kagiya T., Simpson P.C. Effects of pertussis toxin on alpha 1-agonist-mediated phosphatidylinositide turnover and myocardial cell hypertrophy in neonatal rat ventricular myocytes. Experientia 1990, 46:81-84.
11. Katz A.M. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N. Engl. J. Med. 1990, 322:100-110.
12. Landschulz W.H., Johnson P.F., Adashi E.Y., Graves B.J., McKnight S.L. Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev. 1988, 2:786-800.
13. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 1990, 322:1561-1566.
14. Li Y., Ha T., Gao X., Kelley J., Williams D.L., Browder I.W., Kao R.L., Li C. NF-kappaB activation is required for the development of cardiac hypertrophy in vivo. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H1712-H1720.
15. Liu Q.H., Chen Y., Auger-Messier M., Molkentin J.D. Interaction between NF kappa B and NFAT coordinates cardiac hypertrophy and pathological remodeling. Circ. Res. 2012, 110:U 1077-U1138.
16. Molkentin J.D. The transcription factor C/EBPbeta serves as a master regulator of physiologic cardiac hypertrophy. Circ. Res. 2011, 108:277-278.
17. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., Grant S.R., Olson E.N. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93:215-228.
18. Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 2007, 17:318-324.
19. Oh M., Dey A., Gerard R.D., Hill J.A., Rothermel B.A. The CCAAT/enhancer binding protein beta (C/EBP beta) cooperates with NFAT to control expression of the calcineurin regulatory protein RCAN1-4. J. Biol. Chem. 2010, 285:16623-16631.
20. Oh M., Dey A., Gerard R.D., Hill J.A., Rothermel B.A. The CCAAT/enhancer binding protein beta (C/EBPbeta) cooperates with NFAT to control expression of the calcineurin regulatory protein RCAN1-4. J. Biol. Chem. 2010, 285:16623-16631.
21. Prasad A.M., Inesi G. Effects of thapsigargin and phenylephrine on calcineurin and protein kinase C signaling functions in cardiac myocytes. Am. J. Physiol. Cell Physiol. 2009, 296:C992-C1002.
22. Purcell N.H., Tang G.L., Yu C.F., Mercurio F., DiDonato J.A., Lin A.N. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc. Natl. Acad. Sci. USA 2001, 98:6668-6673.
23. Rahman S.M., Janssen R.C., Choudhury M., Baquero K.C., Aikens R.M., de la Houssaye B.A., Friedman J.E. CCAAT/enhancer-binding protein beta (C/EBPbeta) expression regulates dietary-induced inflammation in macrophages and adipose tissue in mice. J. Biol. Chem. 2012, 287:34349-34360.
24. Ramji D.P., Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 2002, 365:561-575.
25. Sebastian T., Johnson P.F. Stop and go: anti-proliferative and mitogenic functions of the transcription factor C/EBPbeta. Cell Cycle 2006, 5:953-957.
26. Zahnow C.A. CCAAT/enhancer binding proteins in normal mammary development and breast cancer. Breast Cancer Res. 2002, 4:113-121.
27. Zhang C.G., Jia Z.Q., Li B.H., Zhang H., Liu Y.N., Chen P., Ma K.T., Zhou C.Y. Beta-Catenin/TCF/LEF1 can directly regulate phenylephrine-induced cell hypertrophy and Anf transcription in cardiomyocytes. Biochem. Biophys. Res. Commun. 2009, 390:258-262.
28. Zhu S., Yoon K., Sterneck E., Johnson P.F., Smart R.C. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc. Natl. Acad. Sci. USA 2002, 99:207-212.
29. Zou J., Le K., Xu S., Chen J., Liu Z., Chao X., Geng B., Luo J., Zeng S., Ye J., Liu P. Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4. Mol. Cell. Endocrinol. 2013, 370:103-112.